Traumatic Glaucoma Flashcards
What does the size of a hyphaema indicate?
The size of a hyphaema is a useful indicator of visual prognosis and risk of complications.
What is the incidence of complications for a hyphaema involving less than half the anterior chamber?
A hyphaema involving less than half the anterior chamber is associated with a 20% incidence of complications.
What is the final visual acuity (VA) outcome for 80% of eyes with a hyphaema involving less than half the anterior chamber?
A final VA of better than 6/18 in 80% of eyes.
What is the incidence of complications when more than half the anterior chamber is involved?
An 80% incidence of complications.
A final visual acuity (VA) of better than 6/18 is seen in only one third of cases.
What primarily determines the visual prognosis after an eye injury?
The extent of injury to the retina sustained at the time of the original injury.
What can severe and prolonged elevation of intraocular pressure (IOP) cause?
Corneal blood staining and damage to the optic nerve.
At what IOP is the optic nerve endangered?
IOP greater than 50 mmHg.
When may secondary hemorrhage develop after an eye injury?
Within 3-5 days of the initial injury and is assoxiated with worse outcome
What is the risk associated with patients who have sickle-cell haemoglobinopathy?
Increased risk of complications, especially IOP elevation due to trabecular meshwork obstruction.
What should be excluded in the general treatment of eye injuries?
A coagulation abnormality, particularly a haemoglobinopathy.
What should be done with current anticoagulant medication?
It should be discontinued after liaison with a general physician to assess the risk.
What is recommended regarding activity for patients with a large hyphaema?
Substantially limiting activity is prudent, and the patient should remain in a sitting or semi-upright posture.
What should be worn for protection in eye injuries?
A protective eye shield.
What medications may be administered depending on the IOP?
Topical prostaglandins, beta-blockers, and/or a topical or systemic carbonic anhydrase inhibitor (CAI).
CAI should not be used in sickle haemoglobinopathies.
What should be avoided in patients with eye injuries?
Miotics, as they may increase pupillary block and disrupt the blood-aqueous barrier.